New Assay Kit from NanoString for miRNA Analysis

NanoString Technologies, Inc., a privately held life sciences company marketing a complete solution for detecting and counting large sets of target molecules in biological samples, today announced a unique new product for miRNA analysis that includes a multiplexed assay for profiling the human miRNA transcriptome in a single tube.

NanoString now offers assays for both gene expression and miRNA analysis for its fully automated nCounter Analysis System

The company introduced the new assay kit, which expands the applications for its nCounter Analysis System, at the American Association for Cancer Research annual meeting.

MicroRNAs (miRNAs) are small, single-stranded, non-coding RNA molecules that have generated intense interest in the scientific community for their recently discovered roles in tumor formation and important biological processes. The primary application areas of miRNA studies are in cancer, neurobiology, developmental biology, and stem cell research.

The nCounter miRNA Expression Assay Kits enable researchers to perform highly multiplexed, direct digital detection and counting of miRNAs at single-base resolution, without the need for PCR amplification. NanoString's Human miRNA Expression Assay Kit enables researchers to profile more than 700 human and human-viral miRNAs with specificity and sensitivity comparable to qPCR at a fraction of the cost.

Carlo Croce, Ph.D., a leading miRNA researcher, was part of an early access program for the Human miRNA Expression Assay Kit on the nCounter Analysis System at the Ohio State University Comprehensive Cancer Center Nucleic Acids Shared Resource directed by Hansjuerg Alder, Ph.D.

"NanoString has developed a true breakthrough in miRNA research technology," said Dr. Croce, "Researchers now have a powerful new tool to study miRNAs in cancer and other disease states, as well to develop potential diagnostic and therapeutic strategies to mitigate the effects of abnormal miRNA expression."

The nCounter Analysis System is a fully automated target profiling system that is extraordinarily easy to use. The assay kits contain all of the reagents and consumables required to conduct miRNA and gene expression experiments.

"We are excited to be the first to deliver scientists an eagerly awaited solution that bridges the gap between the multiplexing available with microarrays, and the required performance of qPCR with less complexity and lower cost," said Wayne Burns, acting CEO of NanoString Technologies. "Combined with the gold-standard levels of sensitivity, specificity, precision, and linearity of the nCounter Analysis System, the new miRNA assay kits offers scientists a comprehensive, efficient, and cost-effective way to study these clinically important molecules."

In addition to the new miRNA assays, the company is developing assays for copy number variation. NanoString also offers custom and off-the-shelf assays for gene expression analysis.



Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Nanostring Technologies. (2019, February 13). New Assay Kit from NanoString for miRNA Analysis. AZoNano. Retrieved on February 29, 2024 from

  • MLA

    Nanostring Technologies. "New Assay Kit from NanoString for miRNA Analysis". AZoNano. 29 February 2024. <>.

  • Chicago

    Nanostring Technologies. "New Assay Kit from NanoString for miRNA Analysis". AZoNano. (accessed February 29, 2024).

  • Harvard

    Nanostring Technologies. 2019. New Assay Kit from NanoString for miRNA Analysis. AZoNano, viewed 29 February 2024,

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Azthena logo powered by Azthena AI

Your AI Assistant finding answers from trusted AZoM content

Your AI Powered Scientific Assistant

Hi, I'm Azthena, you can trust me to find commercial scientific answers from

A few things you need to know before we start. Please read and accept to continue.

  • Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
  • Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
  • Large Language Models can make mistakes. Consider checking important information.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.